Production (Stage)
Fractyl Health, Inc.
GUTS
$2.06
-$0.11-5.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -614.48% | -30.19% | -47.16% | -- | -- |
| Total Depreciation and Amortization | 447.17% | 486.84% | 148.81% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 102.23% | -62.67% | -8.38% | -- | -- |
| Change in Net Operating Assets | -155.49% | 318.22% | 768.85% | -- | -- |
| Cash from Operations | -114.15% | -60.71% | -63.72% | -- | -- |
| Capital Expenditure | 57.70% | -71.32% | -43.92% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 57.70% | -71.32% | -43.92% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5,350.00% | -3,433.33% | 24.68% | -- | -- |
| Issuance of Common Stock | -99.73% | 917.65% | 4,300.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | -- | -- |
| Cash from Financing | -99.83% | 112.05% | -99.42% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -128.74% | -52.33% | -207.67% | -- | -- |